Discontinued — last reported Q2 '25
STERIS Life Science Member — Selling, general, and administrative increased by 8.1% to $16.00M in Q2 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.1%, from $14.80M to $16.00M. This increase may warrant attention — for this metric, lower values are generally preferred.
Rising costs relative to revenue may indicate increased investment in sales force expansion or administrative bloat.
This metric captures the operating expenses for the Life Science segment that are not directly tied to production, inclu...
Comparable to segment-level SG&A expenses reported by diversified medical technology companies.
ste_segment_life_science_member_selling_general_and_administrative| Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q2 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.15M | $13.15M | $13.15M | $13.15M | $14.55M | $14.55M | $14.55M | $14.55M | $14.80M | $16.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +10.7% | +0.0% | +0.0% | +0.0% | +1.7% | +8.1% |
| YoY Change | — | — | — | — | +10.7% | +10.7% | +10.7% | +10.7% | +1.7% | +8.1% |